论文部分内容阅读
由于社会人口老龄化、免疫损害宿主增加、病原体变迁和抗生素耐药率上升 ,社区获得性肺炎 (CAP)仍然是威胁人群健康的重要疾病 ,近 10多年来 ,β 内酰胺类药物尤其是青霉素的耐药性逐年升高 ,其不再作为治疗CAP的唯一首选药物。本试验以左氧氟沙星治疗CAP ,因国产第 3代头孢类?
Community-acquired pneumonia (CAP) is still an important disease that threatens the health of the population due to the aging of the society, the increase of immunocompromised hosts, the change of pathogens and the increase of the rate of antibiotic resistance. For more than 10 years, β-lactam drugs, especially penicillin Drug resistance increased year by year, it is no longer the only drug of choice for the treatment of CAP. This experiment to levofloxacin treatment of CAP, due to domestic third-generation cephalosporins?